Phibro Animal Health Corp (NASDAQ:PAHC) major shareholder Bfi Co., Llc sold 10,000 shares of Phibro Animal Health stock in a transaction on Wednesday, June 13th. The stock was sold at an average price of $46.60, for a total transaction of $466,000.00. Following the sale, the insider now owns 17,470 shares in the company, valued at $814,102. The sale was disclosed in a document filed with the SEC, which is available through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Bfi Co., Llc also recently made the following trade(s):

  • On Thursday, June 7th, Bfi Co., Llc sold 30,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $46.06, for a total transaction of $1,381,800.00.
  • On Friday, May 25th, Bfi Co., Llc sold 2,600 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.09, for a total transaction of $117,234.00.
  • On Friday, May 18th, Bfi Co., Llc sold 9,930 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.05, for a total transaction of $447,346.50.

NASDAQ:PAHC traded up $0.50 during midday trading on Thursday, hitting $47.00. 5,051 shares of the company were exchanged, compared to its average volume of 100,666. Phibro Animal Health Corp has a fifty-two week low of $32.05 and a fifty-two week high of $48.40. The company has a debt-to-equity ratio of 1.61, a current ratio of 3.17 and a quick ratio of 1.73. The firm has a market capitalization of $1.89 billion, a P/E ratio of 30.93, a P/E/G ratio of 2.78 and a beta of 0.94.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Monday, May 7th. The company reported $0.46 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.02. The firm had revenue of $209.00 million for the quarter, compared to analyst estimates of $203.03 million. Phibro Animal Health had a net margin of 7.24% and a return on equity of 39.91%. Phibro Animal Health’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the business earned $0.37 EPS. sell-side analysts anticipate that Phibro Animal Health Corp will post 1.71 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 27th. Shareholders of record on Wednesday, June 6th will be paid a $0.10 dividend. The ex-dividend date is Tuesday, June 5th. This represents a $0.40 dividend on an annualized basis and a yield of 0.85%. Phibro Animal Health’s dividend payout ratio is presently 26.49%.

PAHC has been the topic of several research analyst reports. ValuEngine upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Wednesday, February 28th. BidaskClub upgraded shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a research note on Wednesday, April 18th. Zacks Investment Research lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Wednesday, April 11th. Finally, Credit Suisse Group lifted their price target on shares of Phibro Animal Health from $39.00 to $42.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 9th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $38.80.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Victory Capital Management Inc. increased its stake in Phibro Animal Health by 22.9% in the first quarter. Victory Capital Management Inc. now owns 6,987 shares of the company’s stock valued at $277,000 after purchasing an additional 1,304 shares during the period. Swiss National Bank increased its stake in Phibro Animal Health by 5.3% in the first quarter. Swiss National Bank now owns 33,600 shares of the company’s stock valued at $1,334,000 after purchasing an additional 1,700 shares during the period. First Trust Advisors LP increased its stake in Phibro Animal Health by 14.4% in the fourth quarter. First Trust Advisors LP now owns 17,571 shares of the company’s stock valued at $589,000 after purchasing an additional 2,212 shares during the period. Citadel Advisors LLC increased its stake in Phibro Animal Health by 25.8% in the first quarter. Citadel Advisors LLC now owns 10,999 shares of the company’s stock valued at $437,000 after purchasing an additional 2,254 shares during the period. Finally, Cambridge Investment Research Advisors Inc. increased its stake in Phibro Animal Health by 15.4% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 17,345 shares of the company’s stock valued at $581,000 after purchasing an additional 2,321 shares during the period. Institutional investors own 48.82% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.